Improved Gastrointestinal Involvement in Systemic Sclerosis after Immunoglobulin Treatment / 대한내과학회지
Korean Journal of Medicine
;
: 213-218, 2017.
Artículo
en Coreano
| WPRIM
| ID: wpr-193477
ABSTRACT
Systemic sclerosis is an intractable clinical subset characterized by diffuse fibrosis, vasculopathy, and immune abnormalities. Diffuse cutaneous systemic sclerosis has a variety of symptoms depending on the internal organs involved, such as the lungs, heart, kidneys, and gastrointestinal system. Gastrointestinal involvement is frequent and one of the major cause of morbidity and mortality. There is no sustained, effective therapy for treating the active gastrointestinal involvement of systemic sclerosis. Although immunoglobulin is commonly used in the treatment of other autoimmune diseases, its effects in the treatment of the gastrointestinal involvement in systemic sclerosis are unclear. Here, we report a patient with a severe cough caused by uncontrolled gastrointestinal involvement in diffuse cutaneous systemic sclerosis treated with immunoglobulin.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Esclerodermia Sistémica
/
Enfermedades Autoinmunes
/
Fibrosis
/
Inmunoglobulinas
/
Mortalidad
/
Tos
/
Esclerodermia Difusa
/
Corazón
/
Riñón
/
Pulmón
Tipo de estudio:
Estudio pronóstico
Límite:
Humanos
Idioma:
Coreano
Revista:
Korean Journal of Medicine
Año:
2017
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS